TMCI
$1.46
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States.
Intraday
Recent News
Treace Medical Concepts, Inc. Q4 2025 Earnings Call Summary
Moby summary of Treace Medical Concepts, Inc.'s Q4 2025 earnings call
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
Despite a revenue dip, Treace Medical Concepts Inc (TMCI) focuses on product innovation and market expansion to drive future growth.
Treace Medical Concepts Q4 Earnings Call Highlights
Treace Medical Concepts (NASDAQ:TMCI) management told investors it is entering what it called a “transformational phase,” expanding beyond its historical Lapiplasty focus to become a broader “comprehensive bunion solutions company.” On the company’s fourth quarter and full-year 2025 earnings call, e
Treace Medical Concepts: Q4 Earnings Snapshot
The Ponte Vedra, Florida-based company said it had a loss of 15 cents per share. Losses, adjusted to extinguish debt, were 12 cents per share. The results beat Wall Street expectations.
UFP Technologies (UFPT) Q4 Earnings Top Estimates
UFP (UFPT) delivered earnings and revenue surprises of +7.81% and -1.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?